# OnCo record biosimilar (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/biosimilar/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "biosimilar" ;
  schema:name "Biosimilar"@en ;
  schema:alternateName "biosimilars"@en, "biosimilar competition"@en, "biosimilar uptake"@en, "biosimilar versions"@en, "biosimilar entry"@en, "biosimilar switching"@en ;
  schema:description "A biosimilar is a copy of a biologic drug such as trastuzumab, shown to be as safe and effective as the original once its patent expires, usually at a lower price."@en ;
  schema:url <https://onco.cc/terms/biosimilar/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Biosimilar> ;
  owl:sameAs <http://www.wikidata.org/entity/Q864715> ;
  schema:citation <https://en.wikipedia.org/wiki/Biosimilar> ;
  onco:related <https://onco.cc/terms/bpcia/>, <https://onco.cc/terms/hatch-waxman/>, <https://onco.cc/terms/us-regulatory-exclusivity/>, <https://onco.cc/terms/eu-data-exclusivity/>, <https://onco.cc/terms/spc/>, <https://onco.cc/terms/china-vbp-nrdl/>, <https://onco.cc/terms/eu-pharma-package/>, <https://onco.cc/terms/inflation-reduction-act/> ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-biosimilars/>, <https://onco.cc/drugs/trastuzumab/> .